Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription

Articles published in PLoS Genet

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    April 2021
  1. INGLES-PRIETO A, Furthmann N, Crossman SH, Tichy AM, et al
    Optogenetic delivery of trophic signals in a genetic model of Parkinson's disease.
    PLoS Genet. 2021;17:e1009479.
    PubMed     Abstract available

    February 2021
  2. SARKAR S, Olsen AL, Sygnecka K, Lohr KM, et al
    alpha-synuclein impairs autophagosome maturation through abnormal actin stabilization.
    PLoS Genet. 2021;17:e1009359.
    PubMed     Abstract available

  3. JEWETT KA, Thomas RE, Phan CQ, Lin B, et al
    Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.
    PLoS Genet. 2021;17:e1008859.
    PubMed     Abstract available

    November 2020
  4. DICK F, Nido GS, Alves GW, Tysnes OB, et al
    Differential transcript usage in the Parkinson's disease brain.
    PLoS Genet. 2020;16:e1009182.
    PubMed     Abstract available

    October 2020
  5. TERRIENTE-FELIX A, Wilson EL, Whitworth AJ
    Drosophila phosphatidylinositol-4 kinase fwd promotes mitochondrial fission and can suppress Pink1/parkin phenotypes.
    PLoS Genet. 2020;16:e1008844.
    PubMed     Abstract available

    June 2020
  6. KAO CY, Xu M, Wang L, Lin SC, et al
    Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
    PLoS Genet. 2020;16:e1008868.
    PubMed     Abstract available

    February 2020
  7. RAMDHANI S, Navarro E, Udine E, Efthymiou AG, et al
    Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs.
    PLoS Genet. 2020;16:e1008549.
    PubMed     Abstract available

    August 2019
  8. GIGUERE N, Delignat-Lavaud B, Herborg F, Voisin A, et al
    Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.
    PLoS Genet. 2019;15:e1008352.
    PubMed     Abstract available

    September 2018
  9. THOMAS RE, Vincow ES, Merrihew GE, MacCoss MJ, et al
    Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles.
    PLoS Genet. 2018;14:e1007694.
    PubMed     Abstract available

    March 2018
  10. GIBSON CL, Balbona JT, Niedzwiecki A, Rodriguez P, et al
    Glial loss of the metallo beta-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration.
    PLoS Genet. 2018;14:e1007269.
    PubMed     Abstract available

  11. TAS D, Stickley L, Miozzo F, Koch R, et al
    Parallel roles of transcription factors dFOXO and FER2 in the development and maintenance of dopaminergic neurons.
    PLoS Genet. 2018;14:e1007271.
    PubMed     Abstract available

    November 2017
  12. FERNANDEZ MV, Kim JH, Budde JP, Black K, et al
    Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.
    PLoS Genet. 2017;13:e1007045.
    PubMed     Abstract available

    August 2017
  13. YANG J, Kim MJ, Yoon W, Kim EY, et al
    Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
    PLoS Genet. 2017;13:e1006975.
    PubMed     Abstract available

    May 2017
  14. ISAKSEN TJ, Kros L, Vedovato N, Holm TH, et al
    Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump.
    PLoS Genet. 2017;13:e1006763.
    PubMed     Abstract available

    October 2016
  15. DING L, Lei Y, Han Y, Li Y, et al
    Vimar Is a Novel Regulator of Mitochondrial Fission through Miro.
    PLoS Genet. 2016;12:e1006359.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.